	US 11,903,982 B2
	Methods of treating pseudomonas aeruginosa respiratory infections
Rozenn Le Berre, Brest (FR); Marie-Sarah Fangous, Quimper (FR); Gwenaelle Le Blay, Plouzané (FR); Geneviève Hery-Arnaud, Brest (FR); and Rosyne Lagrafeuille, Brest (FR)
Assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), Paris (FR); ETABLISSEMENT FRANCAIS DU SANG (EFS), La Plaine Saint Denis (FR); UNIVERSITE DE BRETAGNE OCCIDENTALE, Brest (FR); and CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST, Brest (FR)
Filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Paris (FR); Etablissement Français du Sang (EFS), La Plaine Saint Denis (FR); Université de Bretagne Occidentale, Brest (FR); and Centre Hospitalier Regional et Universitaire de Brest, Brest (FR)
Filed on May 10, 2022, as Appl. No. 17/740,819.
Application 17/740,819 is a continuation of application No. 17/049,221, granted, now 11,364,271, previously published as PCT/EP2019/060214, filed on Apr. 19, 2019.
Claims priority of application No. 18305486 (EP), filed on Apr. 20, 2018.
Prior Publication US 2022/0331379 A1, Oct. 20, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 63/00 (2020.01); A61K 35/747 (2015.01); A61P 31/04 (2006.01); A61P 11/00 (2006.01)

CPC A61K 35/747 (2013.01) [A61P 11/00 (2018.01); A61P 31/04 (2018.01)]

8 Claims

1. A method of treating a Pseudomonas aeruginosa respiratory tract infection in a patient in need thereof comprising administering to the patient's respiratory tract a therapeutically effective amount of at least one Lactobacillus strain, wherein administration to the patient's respiratory tract comprises administration to a lung of the patient.